Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PRP for Lumbar DDD and Facet Joint Syndrome
NCT04816747Phase 3Unknown
- Start
- Apr 2022
- Primary completion
- Oct 2024
- Modality
- Adoptive Cell Transfer
01
Overview
A Phase 3 trial of autologous platelet-rich plasma in Facet joint syndrome (FJS). Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Facet joint syndrome (FJS)
Beyond the preview
Go deeper on NCT04816747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04816747.